Atlas Trials

Study to Investigate the Efficacy and Safety of Mexiletine in Patients With Myotonic Dystrophy Type 1 and Type 2

Clinical trial NCT04700046 · WITHDRAWN

Trial details

NCT number
NCT04700046
Sponsor
Lupin Ltd.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Myotonic Dystrophy Type 1 and Type 2
Start date
2021-09-03
Primary completion
2024-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.